What is iUTMB?
Set iUTMB pref.
Suggest link

Employees
Accounting
Benefits
Compliance
EAP
Equal Opp. and Diversity
Human Resources
International Affairs
Jobline
Online Training
Payroll Services
Personal Health Mgmt.
Policies and Procedures
Referral Bonus
Suggestions
Service Day
UPS Express Shipping

UT System 
  Business Procedures
  Components
  Employee Advisory C.

Holiday Schedule
Holiday FAQ

Retirees

Students
Alumni
Campus Housing
Computer Support
Enrollment Services
Student Life
Student Services
Student Wellness
Web CT
SON Web CT

Faculty
Salary Equity Study
Core Com. for Women
Faculty Resources
SOM e-News
Faculty Leaves
Faculty Senate
Medical Staff Bylaws

Clinical
Clinical Operations
ClinWeb
Correctional Care
EMR Demo Info
Nursing Service
JCAHO
Lab Survival Guide
Patient Safety

Research
VP for Research
Core Facilities
Infection and Immunity
Neurosciences
StarLine
Yellow Sheet
 

Information Services
Access Management
Change Password
EMR Demo Info
Exchange Webmail
HelpDesk
Remote Access Info
Security Initiative
Computer Virus Info

• RTOG 95-12 A RANDOMIZED STUDY OF HYPERFRACTIONATION
  VERSUS CONVENTIONAL FRACTIONATION IN T2 SQUAMOUS CELL
  CARCINOMA OF THE VOCAL CORD
  Eligibility Schema
   

• RTOG 99-03 A RANDOMIZED PHASE III TRIAL TO ASSESS THE EFFECT OF ERYTHROPOIETIN ON LOCAL-REGIONAL CONTROL IN ANEMIC PATIENTS TREATED WITH RADIOTHERAPY FOR CARCINOMA OF THE HEAD AND NECK
  Eligibility Schema
   

• RTOG 9911 PHASE II STUDY OF PACLITAXEL AND CISPLATIN IN COMBINATION WITH SPLIT COURSE CONCOMITANT HYPERFRACTIONATED RE-IRRADIATION IN PATIENTS WITH RECURRENT SQUAMOUS CELL CANCER OF THE HEAD AND NECK
  Eligibility Schema
   

• RTOG H-0022 PHASE I/II STUDY OF CONFORMAL AND INTENSITY MODULATED IRRADIATION FOR OROPHARYNGEAL CANCER
  Eligibility Schema
   

• RTOG H-0024 PHASE II TRIAL OF EARLY POSTOPERATIVE PACLITAXEL FOLLOWED BY PACLITAXEL AND CISPLATIN CONCURRENT WITH RADIATION THERAPY FOR RESECTED, HIGH-RISK SQUAMOUS CARCINOMA OF THE HEAD AND NECK
  Eligibility Schema CLOSED TO ACCRUAL
   

• RTOG H-0129 A PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMAS
  Eligibility Schema
   

• RTOG 0225; A PHASE II STUDY OF INTENSITY MODULATED RADIATION THERAPY (IMRT) +/- CHEMOTHERAPY FOR NASOPHARYNGEAL CANCER
  Eligibility Schema
   

Radiation Oncology

Patient Information

Our Physicians

Treatment Machines

Hours of Operation

RTOG Research Protocols

Other Research Protocols

    Head & Neck

    Prostate

Residency Application

Physics

Biology

Atlas of Organs at Risk

Remote Support

Remote Support
OnCampus